Skip to main content

Advertisement

SpringerLink
Log in

RETRACTED ARTICLE: The Clinical Utility of Matrix Metalloproteinase 9 in Evaluating Pathological Grade and Prognosis of Glioma Patients: A Meta-Analysis

  • Published:
Molecular Neurobiology Aims and scope Submit manuscript

This article was retracted on 20 January 2017

This article has been updated

Abstract

In the recent years, matrix metalloproteinase 9 (MMP-9) has been focused on as an indicator of glioma grade and prognosis, especially in China. However, all results resulted in many conflicts. So, it is necessary to conduct a meta-analysis to secure a convincing correlation between MMP-9 and grade and prognosis. Eligible studies were included via multiple searches, and then odds ratios (ORs) and hazard ratios (HRs) with 95 % confidence intervals (95 % CIs) were estimated. Funnel plots were available for evaluation of publication bias. In addition, heterogeneity and sensitivity were also analyzed. In the present meta-analysis, 23 articles were allowed for inclusion with total 1,635 patients. Coincidentally, all studies were conducted in Chinese populations. High MMP-9 expression in gliomas was closely associated with high WHO grade (III+IV) (n = 22, OR = 5.25, 95 % CI = 4.09–6.73; p = 0.000), while MMP-9 expression did not correlate to age (n = 4, OR = 1.02, 95 % CI = 0.67–1.54; p = 0.929) and gender (n = 5, OR = 0.91, 95 % CI = 0.63–1.33; p = 0.632). Besides, overall survival analysis from two articles revealed MMP-9 expression significantly predicted 5-year-OS (HR = 6.44, 95 % CI = 3.88–10.70; p = 0.000) in glioma patients. No heterogeneity and publication bias were observed across all studies. To conclude, this meta-analysis suggests MMP-9 is potently associated with high grade and poor 5 years prognosis, and MMP-9 test of glioma tissues should be established in department of pathology as a routine in clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Change history

  • 20 January 2017

    An erratum to this article has been published.

References

  1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97–109

    Article  PubMed  PubMed Central  Google Scholar 

  2. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61(3):215–225

    Article  PubMed  Google Scholar 

  3. Stetler-Stevenson WG (1990) Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev 9(4):289–303

    Article  CAS  PubMed  Google Scholar 

  4. Roy R, Yang J, Moses MA (2009) Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol 27(31):5287–5297

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Choi JY, Jang YS, Min SY, Song JY (2011) Overexpression of MMP-9 and HIF-1a in breast cancer cells under hypoxic conditions. J Breast Cancer 14(2):88–95

    Article  PubMed  PubMed Central  Google Scholar 

  6. Aalinkeel R, Nair BB, Reynolds JL, Sykes DE, Mahajan SD, Chadha KC, Schwartz SA (2011) Overexpression of MMP-9 contributes to invasiveness of prostate cancer cell line LNCaP. Immunol Invest 40(5):447–464

    Article  CAS  PubMed  Google Scholar 

  7. Kumar B, Koul S, Petersen J, Khandrika L, Hwa JS, Meacham RB, Wilson S, Koul HK (2010) p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity. Cancer Res 70(2):832–841

    Article  CAS  PubMed  Google Scholar 

  8. Choe G, Park JK, Jouben-Steele L, Kremen TJ, Liau LM, Vinters HV, Cloughesy TF, Mischel PS (2002) Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype. Clin Cancer Res 8(9):2894–2901

    CAS  PubMed  Google Scholar 

  9. Gabayan AJ, Green SB, Sanan A, Jenrette J, Schultz C, Papagikos M, Tatter SP, Patel A, Amin P, Lustig R, Bastin KT, Watson G, Burri S, Stea B (2006) GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multiinstitutional analysis. Neurosurgery 58(4):701–709

    Article  PubMed  Google Scholar 

  10. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, National Cancer Institute of Canada Clinical Trials Group (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996

    Article  CAS  PubMed  Google Scholar 

  11. Zhao W, Zhuang W, Li G, Cui Y, Zhong S, Yuan F (2012) Differential expression of MMP-9 and AQP4 in human glioma samples. Folia Neuropathol 50(2):176–186

    PubMed  Google Scholar 

  12. Steels E, Paesmans M, Berghmans T, Branle F, Lemaitre F, Mascaux C, Meert AP, Vallot F, Lafitte JJ, Sculier JP (2001) Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis. Eur Respir J 18(4):705–719

    Article  CAS  PubMed  Google Scholar 

  13. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8(1):16

    Article  PubMed  PubMed Central  Google Scholar 

  14. Parmar MK, Torri V, Stewart L (1998) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17(24):2815–2834

    Article  CAS  PubMed  Google Scholar 

  15. Sterne JA, Egger M (2001) Funnel plots for detecting bias in meta-analysis: Guidelines on choice of axis. J Clin Epidemiol 54(10):1046–1055

    Article  CAS  PubMed  Google Scholar 

  16. Jiang C, Chen J, He L, Lin Z, Huang G (2001) Role of MMP-2 and MMP-9 in primary human brain gliomas invasion. Acta Anatom Sin 32(4):346–349

    CAS  Google Scholar 

  17. Liu Y, Zhou Y, Zhang X, Shen B (2011) Expression of VEGF and MMP-9, and their correlation with MRI imaging changes in cerebral glioma. Oncol Lett 2(6):1171–1175

    PubMed  PubMed Central  Google Scholar 

  18. Cao X (2004) Relationship between the expression of VEGF, MMP9 and pathology, MRI in glioma. Hebei Med Univ 1(1):13–15

    Google Scholar 

  19. Kang C, Pu P, Li J, Yu S, Wang H, Jiang R, Dong L, Wang G (2004) Expression of MMP2, MMP9 and Ki-67 in human gliomas. Chin Tumor Clin 31(14):820–823

    CAS  Google Scholar 

  20. Yang X, Wang M, Liu S, Wang T, Wang H (2004) Significance of matrix metalloproteinase-9 expression for prevention and treatment of glioma, and its correlation with angiogenesis. Chin J Clin Rehab 8(23):4779–4782

    CAS  Google Scholar 

  21. Wang H, Pu P, Wang G, Dong L, Kang C, Li J, Wang C, Jiao D (2005) Expression of PTEN, MMP2 and MMP9 in gliomas. Chin Neurol Psychiat 31(4):419–421

    CAS  Google Scholar 

  22. Yu H, Yang W, Shi S (2005) Expression and correlation of ICAM-1 and MMP-9 in human glioma. Chin J Neurol 4(9):911–913

    Google Scholar 

  23. Zhang JP (2006) Expression and correlative study of MMP-9, E-cad and PTEN gene in glioma. Jinan Univ 1(1):5–7

    Google Scholar 

  24. Du Q, Yu W, Dong X (2009) Expression of OPN and MMP-9 in human glioma and their clinical significance. Zhejiang Med 31(6):729–734

    CAS  Google Scholar 

  25. Li F, Yang X (2009) Expression and significance of HIF-1, MMP-9, and VEGF in gliomas. Acta Acad Xuzhou Med 29(10):680–681

    Google Scholar 

  26. Shi H (2009) Expression and significance of OPN, MMP-9 and MVD in brain gliomas. Hebei Med Univ 1(1):18–20

    Google Scholar 

  27. Cui Y (2010) Expression and significance of EGFR, MMP9, and Ki67 in gliomas. Hebei Univ 1(1):5–7

    Google Scholar 

  28. Sun R, Xu G (2010) Expressions of VEGF and MMP-9 in human gliomas and their meanings. Chin J Clin Neurosurg 15(5):273–277

    Google Scholar 

  29. Ju H, Shen S, Geng H, Xie L, Guo J, Jiang J, Zhang W, Wang L, Wang X (2011) Expression and correlation of CD147, MMP9 and TIMP-1 in gliomas of different grade. Chin Clin Med 27(5):461–464

    Google Scholar 

  30. Hao D (2012) Expression and significance of COX-2, MMP-9 and VEGF in human gliomas. Shanxi Med Univ 1(1):6–8

    Google Scholar 

  31. Hui X, Ding L, Jiang J, Wang X (2012) Expression and significance of Cath-D and MMP9 in postoperative gliomas. Chin Old Man 32(19):4259–4260

    CAS  Google Scholar 

  32. Ma Q (2012) Expression and clinical significance of MMP-9 and CDl33 protein in human gliomas. Jinan Univ 1(1):8–12

    Google Scholar 

  33. Sun Z, Wang L, Gu F, Fu L, Li W, Ma Y (2012) Expression of Notchl, MMP-2 and MMP-9 and their significance in glioma patients. Chin J Oncol 34(1):26–30

    Google Scholar 

  34. Zhao J, Li G, Zhao Z, Wang J, Gao G, He S (2012) Matrix metalloproteinase-9 expression is increased in astrocytic glioma and associated with prognosis of patients. Jpn J Clin Oncol 42(11):1060–1065

    Article  PubMed  Google Scholar 

  35. Zhong H, Li Q, Li B, Cai L (2013) Significance and expression of intergrin and matrix metalloproteinase-9 in human brain glioma. Chin J Exp Surg 30(6):1298–1299

    CAS  Google Scholar 

  36. Ma C, Li Y, Zhang X, Zhao G, Xu H (2014) Levels of vascular endothelial growth factor and matrix metalloproteinase-9 proteins in patients with glioma. J Int Med Res 42(1):198–204

    Article  CAS  PubMed  Google Scholar 

  37. Ahmed R, Oborski MJ, Hwang M, Lieberman FS, Mountz JM (2014) Malignant gliomas: Current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods. Cancer Manag Res 6:149–170

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Begg CB, Berlin JA (1988) Publication bias: a problem in interpreting medical data. J R Stat Soc A 81(2):107–115

    Google Scholar 

Download references

Acknowledgments

This study was supported by Shandong University Science Technology Innovation Foundation (201410422123). We greatly thank Sera Kwon in Sandy lab for valuable suggestions and writing.

Conflict of interest

The authors state that there are no conflicts of interest to disclose.

Author information

Authors and Affiliations

  1. Department of Pathology, Affiliated Hospital of Shandong Academy of Medical Sciences, Jinan, Shandong, China

    Xiangshan Yang

  2. Shandong University School of Medicine, Jinan, Shandong, China

    Shunzeng Lv, Ranran Shi, Zhenyu Tang & Jianzhen Fan

  3. Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

    Yuting Liu

  4. Department of Thoracic Surgery, Affiliated Hospital of Shandong Academy of Medical Sciences, Jinan, Shandong, China

    Daotang Li

  5. Department of General Surgery, Affiliated Hospital of Shandong Academy of Medical Sciences, 38# wuyingshan Road, Jinan, Shandong, China

    Zhongfa Xu

Authors
  1. Xiangshan Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shunzeng Lv
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yuting Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daotang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ranran Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zhenyu Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jianzhen Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Zhongfa Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhongfa Xu.

Additional information

This article has been retracted at the request of the Editor-in-Chief and the Publisher per the Committee on Publication Ethics guidelines. There is strong reason to believe that the peer review process was compromised and the authors have plagiarized parts from the following article:

Shunzeng Lv, Congxin Dai, Yuting Liu, Ranran Shi, Zhenyu Tang, Mingzhi Han, Ruixiang Bian, Bowen Sun, Renzhi Wang, The Impact of Survivin on Prognosis and Clinicopathology of Glioma Patients: A Systematic Meta-Analysis, Molecular Neurobiology June 2015, Volume 51, Issue 3, pp 1462–1467, DOI:10.1007/s12035-014-8823-5Received: 26 June 2014.

In addition, the article shows similarities with the following article which was submitted within a close timeframe:

Xiangshan Yang, Shunzeng Lv, Xingtong Zhou, Yuting Liu, Daotang Li, Ranran Shi, Huihui Kang, Jing Zhang, Zhongfa Xu, The Clinical Implications of Transforming Growth Factor Beta in Pathological Grade and Prognosis of Glioma Patients: A Meta-Analysis, Molecular Neurobiology August 2015, Volume 52, Issue 1, pp 270–276, DOI: 10.1007/s12035-014-8872-9Received: 6 August 2014.

The article “The Clinical Utility of Matrix Metalloproteinase 9 in Evaluating Pathological Grade and Prognosis of Glioma Patients: A Meta-Analysis” was received: 20 July 2014.

As such the validity of the content of this article cannot be verified.

An erratum to this article is available at https://doi.org/10.1007/s12035-017-0408-7.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, X., Lv, S., Liu, Y. et al. RETRACTED ARTICLE: The Clinical Utility of Matrix Metalloproteinase 9 in Evaluating Pathological Grade and Prognosis of Glioma Patients: A Meta-Analysis. Mol Neurobiol 52, 38–44 (2015). https://doi.org/10.1007/s12035-014-8850-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12035-014-8850-2

Keywords

Search

Navigation